Véronique Hofman

Laboratory of Clinical and Experimental Pathology, Centre Hospitalier Universitaire de Nice

Université Côte d’Azur, CHU de Nice

Biography
Publications
Institution
JoVE Articles

Véronique Hofman has not added a biography.

If you are Véronique Hofman and would like to personalize this page please email our Author Liaison for assistance.

Publications

The Need to Set Up a Biobank Dedicated to Lymphoid Malignancies: Experience of a Single Center (Laboratory of Clinical and Experimental Pathology, University Côte D'Azur, Nice, France)
Journal of Personalized Medicine. Jun, 2023 | Pubmed ID: 37511690
Epithelial-to-mesenchymal Transition Promotes Immune Escape by Inducing CD70 in Non-small Cell Lung Cancer
European Journal of Cancer (Oxford, England : 1990). Jul, 2022 | Pubmed ID: 35550950
[Oncothoracic Pathology Seminar: Case No. 1]
Annales De Pathologie. Mar, 2022 | Pubmed ID: 34998625
[Oncothoracic Pathology Seminar: Case No. 2]
Annales De Pathologie. Mar, 2022 | Pubmed ID: 34996647
Salivary Detection of COVID-19: Clinical Performance of Oral Sponge Sampling for SARS-CoV-2 Testing
ERJ Open Research. Oct, 2021 | Pubmed ID: 34877351
CT-guided Percutaneous Biopsies of Mediastinal and Paramediastinal Masses in the Lateral Decubitus Position
European Radiology. Jun, 2020 | Pubmed ID: 32065281
Critical Assessment in Routine Clinical Practice of Liquid Biopsy for EGFR Status Testing in Non-Small-Cell Lung Cancer: A Single-Laboratory Experience (LPCE, Nice, France)
Clinical Lung Cancer. Jan, 2020 | Pubmed ID: 31519454
A Case Report of Exogenous Lipoid Pneumonia Associated with Avocado/soybean Unsaponifiables
BMC Pulmonary Medicine. Dec, 2019 | Pubmed ID: 31795982
[Pseudotumor Lesions Induced by Infectious Agents. Case N 5]
Annales De Pathologie. Aug, 2019 | Pubmed ID: 31303345
[Pseudo Tumor Lesions Induced by Infectious Agents. Case N°6]
Annales De Pathologie. Aug, 2019 | Pubmed ID: 31301879
Circulating Tumor Cell Detection in Lung Cancer: But to What End?
Cancers. Feb, 2019 | Pubmed ID: 30813420
[The Age of Artificial Intelligence in Lung Cancer Pathology: Between Hope, Gloom and Perspectives]
Annales De Pathologie. Apr, 2019 | Pubmed ID: 30772062
Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma
Cancers. Sep, 2018 | Pubmed ID: 30216999
Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?
Cancers. Jun, 2018 | Pubmed ID: 29966305
Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections Through the Encapsulation of Dried DNA
Cancers. Jun, 2018 | Pubmed ID: 29891792
Effect of Mutant Variants of the KRAS Gene on PD-L1 Expression and on the Immune Microenvironment and Association with Clinical Outcome in Lung Adenocarcinoma Patients
Lung Cancer (Amsterdam, Netherlands). Jul, 2018 | Pubmed ID: 29858030
E2F1 Inhibition Mediates Cell Death of Metastatic Melanoma
Cell Death & Disease. 05, 2018 | Pubmed ID: 29743521
Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients
Cancers. Mar, 2018 | Pubmed ID: 29561830
Any Place for Immunohistochemistry Within the Predictive Biomarkers of Treatment in Lung Cancer Patients?
Cancers. Mar, 2018 | Pubmed ID: 29534030
Use of Circulating Tumor Cells in Prospective Clinical Trials for NSCLC Patients - Standardization of the Pre-analytical Conditions
Clinical Chemistry and Laboratory Medicine. May, 2018 | Pubmed ID: 29397019
Circulating Tumour Cells As a Potential Screening Tool for Lung Cancer (the AIR Study): Protocol of a Prospective Multicentre Cohort Study in France
BMJ Open. 12, 2017 | Pubmed ID: 29282271
Use of the 22C3 Anti-PD-L1 Antibody to Determine PD-L1 Expression in Multiple Automated Immunohistochemistry Platforms
PloS One. 2017 | Pubmed ID: 28797130
Annales De Pathologie. Aug, 2017 | Pubmed ID: 28778623
Expression of MET in Circulating Tumor Cells Correlates with Expression in Tumor Tissue from Advanced-stage Lung Cancer Patients
Oncotarget. Apr, 2017 | Pubmed ID: 28212540
[PD1/PD-L1 Immunohistochemistry in Thoracic Oncology: Where Are We?]
Annales De Pathologie. Feb, 2017 | Pubmed ID: 28159404

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Christophe Bontoux^1,2,3,4,5, Virginie Lespinet-Fabre^1,2,3,4, Olivier Bordone^1,2,3,4, Virginie Tanga^1,2,3,4, Maryline Allegra^1,2,3,4, Myriam Salah^1,2,3,4, Salomé Lalvée^1,2,3,4, Samantha Goffinet^1,2,3,4, Jonathan Benzaquen^3,4,5,6, Charles-Hugo Marquette^3,4,5,6, Marius Ilié^1,2,3,4,5, Véronique Hofman^1,2,3,4,5, Paul Hofman^1,2,3,4,5

¹Laboratory of Clinical and Experimental Pathology, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, CHU de Nice, ²Hospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, Hôpital Pasteur, CHU de Nice, ³Institut Hospitalo-Universitaire (IHU), RespirERA, Université Côte d'Azur, Hôpital Pasteur, CHU de Nice, ⁴FHU OncoAge, Université Côte d'Azur, ⁵Team 4, Institute of Research on Cancer and Aging (IRCAN), CNRS INSERM, Centre Antoine-Lacassagne, Université Côte d'Azur, ⁶Department of Pulmonary Medicine and Thoracic Oncology, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur

JoVE 65190

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Marius Ilié^1,2,3, Mélanie Ngo-Mai¹, Elodie Long-Mira^1,2, Sandra Lassalle^1,2, Catherine Butori¹, Coraline Bence¹, Marame Hamila¹, Véronique Hofman^1,2,3, Paul Hofman^1,2,3

¹Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Hospital University Federation OncoAge, Université Côte d’Azur, ²Institute for Research on Cancer and Aging in Nice (Inserm U1081 and CNRS 7284), Université Côte d’Azur, ³Hospital-Integrated Biobank (BB-0033-00025), Pasteur Hospital, Université Côte d’Azur

JoVE 58082

Véronique Hofman has not added a biography.

Publications

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Your free access has ended.